LP-300

· Lantern Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LP-300, covering 2025-11-20 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma [Phase 2]